Thrombolysis for ischemic stroke associated with infective endocarditis: Results from the nationwide inpatient sample

Stroke

Volumn 44, Issue 10, 2013, Pages 2917-2919

  Asaithambi, Ganesh ^a   Adil, Malik M ^a   Qureshi, Adnan I ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Endocarditis; Outcomes assessment; Stroke; Thrombolytic therapy

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DISEASE ASSOCIATION; FEMALE; FIBRINOLYTIC THERAPY; HOSPITAL CHARGE; HOSPITALIZATION; HUMAN; INTRAVENOUS THROMBOLYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEIZURE; THROMBECTOMY; TREATMENT OUTCOME;

ENDOCARDITIS; OUTCOMES ASSESSMENT; STROKE; THROMBOLYTIC THERAPY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; DATABASES, FACTUAL; ENDOCARDITIS; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; STROKE; THROMBOLYTIC THERAPY; UNITED STATES;

EID: 84888374888     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001602     Document Type: Article

References (11)

1. Kan P, Webb S, Siddiqui AH, Levy EI. First reported use of retrievable stent technology for removal of a large septic embolus in the middle cerebral artery. World Neurosurg. 2012;77:591.e1-591.e5.
2. Bhuva P, Kuo SH, Claude Hemphill J, Lopez GA. Intracranial hemorrhage following thrombolytic use for stroke caused by infective endocarditis. Neurocrit Care. 2010;12:79-82.
3. Dababneh H, Hedna VS, Ford J, Taimeh Z, Peters K, Mocco J et al. Endovascular intervention for acute stroke due to infective endocarditis. Neurosurg Focus. 2012;32:E1.
4. Siccoli M, Benninger D, Schuknecht B, Jenni R, Valavanis A, Bassetti C. Successful intra-arterial thrombolysis in basilar thrombosis secondary to infectious endocarditis. Cerebrovasc Dis. 2003;16:295-297.
5. Sonneville R, Mirabel M, Hajage D, Tubach F, Vignon P, Perez P et al. Neurologic complications and outcomes of infective endocarditis in critically ill patients: The ENDOcardite en REAanimation prospective multicenter study. Crit Care Med 2011;39:1474-1481.
6. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr; American Heart Association Stroke Council. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: A science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40:2945-2948.
7. Sontineni SP, Mooss AN, Andukuri VG, Schima SM, Esterbrooks D. Effectiveness of thrombolytic therapy in acute embolic stroke due to infective endocarditis. Stroke Res Treat 2010;2010:841797.
8. Junna M, Lin CC, Espinosa RE, Rabinstein AA. Successful intravenous thrombolysis in ischemic stroke caused by infective endocarditis. Neurocrit Care. 2007;6:117-120.
9. Anderson DJ, Goldstein LB, Wilkinson WE, Corey GR, Cabell CH, Sanders LL, et al. Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis. Neurology. 2003;61:1341-1346.
10. Birman-Deych E, Waterman AD, Yan Y, Nilasena DS, Radford MJ, Gage BF. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care. 2005;43:480-485.
11. Qureshi AI, Chaudhry SA, Sapkota BL, Rodriguez GJ, Suri MF. Discharge destination as a surrogate for Modified Rankin Scale defined outcomes at 3- And 12-months poststroke among stroke survivors. Arch Phys Med Rehabil. 2012;93:1408-1413.e1.